Lexicon Pharma (LXRX) Reports In-Line Q3 EPS
Tweet
Share
E-mail
Get Alerts LXRX Hot Sheet
Price: $2.30 +0.44%
Revenue Growth %: -86.1%
Financial Fact:
Interest expense: -1.65M
Today's EPS Names:
CGEH, NAKA, APOG, More
Revenue Growth %: -86.1%
Financial Fact:
Interest expense: -1.65M
Today's EPS Names:
CGEH, NAKA, APOG, More
Join SI Premium – FREE
Lexicon Pharma (NASDAQ: LXRX) reported Q3 EPS of ($0.21), in-line with the analyst estimate of ($0.21). Revenue for the quarter came in at $160 thousand versus the consensus estimate of $2.06 million.
For earnings history and earnings-related data on Lexicon Pharma (LXRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk stock target lifted by Citi on continued demand strength
- Trip.com Group (TCOM) Misses Q1 EPS by 41c
- Winnebago Industries (WGO) Misses Q3 EPS by 11c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
